Well, bad news, fellow gluttons. The Food and Drug Administration has yet again decided not to approve a new prescription diet pill. Last October, the FDA denied us the freedom to take amazing new weight-loss drugs called lorcaserin and Qnexa — BTW: Who gets to come up with these names? They sound like awesome creatures from Greek mythology — and today the Times reports that the agency has denied approval to another new diet drug called Contrave. They say Contrave's maker, Orexigen Therapeutics, has to first demonstrate that the drug won't cause heart attacks or something. So! There go our plans for getting back into bikini shape. Now what are we supposed to do? Eat more vegetables? Thanks but no thanks, new USDA dietary guidelines. Guess we'll just have to start drinking more.
Most Viewed Stories
Bartender Says He Received This Patronizing ‘Economics’ Card Instead of an Actual Tip
Chef Sarah Simmons Wants Her Whole Life to Taste Like Barbecued Beef Rib
There’s a New Restaurant That Specializes in Potato-Chip Sandwiches
The First of the ‘Hip’ Whole Foods Spinoff Markets Will Open in Silver Lake, of Course
Grub Street’s Restaurant Power Rankings: Japanese Bar Food, Great New Pizza, and More